Other
Net Change in Cash
United Therapeutics Net Change in Cash decreased by 9.6% to -$277.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 236.9%, from $202.70M to -$277.40M. Over 3 years (FY 2021 to FY 2024), Net Change in Cash shows an upward trend with a 42.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOther
CategoryLiquidity
SignalHigher is better
VolatilityVolatile
First reportedQ1 2017
Last reportedQ1 2026
How to read this metric
A positive change indicates net cash generation, while a negative change indicates cash consumption for the period.
Detailed definition
The total net increase or decrease in cash, cash equivalents, and restricted cash during the reporting period. It is the...
Peer comparison
A fundamental liquidity metric used to compare cash management efficiency across all public companies.
Metric ID:
net_change_in_cashHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $109.90M | -$33.70M | $0.00 | -$81.50M | -$18.10M | $171.60M | $0.00 | $202.30M | -$96.20M | $40.40M | $100.00M | $43.80M | $104.20M | $198.20M | $143.30M | $202.70M | -$306.80M | -$253.00M | -$277.40M |
| QoQ Change | — | -130.7% | +100.0% | — | +77.8% | >999% | -100.0% | — | -147.6% | +142.0% | +147.5% | -56.2% | +137.9% | +90.2% | -27.7% | +41.5% | -251.4% | +17.5% | -9.6% |
| YoY Change | — | — | — | — | -116.5% | +609.2% | — | +348.2% | -431.5% | -76.5% | — | -78.3% | +208.3% | +390.6% | +43.3% | +362.8% | -394.4% | -227.6% | -236.9% |
Range-$306.80M – $202.70M
CAGR+22.8%
Avg YoY Growth+30.8%
Median YoY Growth-76.5%
Net Change in Cash at Other Companies
Frequently Asked Questions
- What is United Therapeutics's net change in cash?
- United Therapeutics (UTHR) reported net change in cash of -$277.40M in Q1 2026.
- How has United Therapeutics's net change in cash changed year-over-year?
- United Therapeutics's net change in cash decreased by 236.9% year-over-year, from $202.70M to -$277.40M.
- What is the long-term trend for United Therapeutics's net change in cash?
- Over 3 years (2021 to 2024), United Therapeutics's net change in cash has grown at a 42.3% compound annual growth rate (CAGR), from $169.80M to $489.50M.
- What does net change in cash mean?
- The total change in the company's cash position over the period.